Skip to main content
. 2022 Jan 28;14(3):579. doi: 10.3390/nu14030579

Figure 8.

Figure 8

Putative effects of lysophosphatidylethanolamine (lysoPE) on hepatic lipid metabolism. The present study demonstrated that lysoPE 18:2 supplementation induced hepatic lipid accumulation and caused lipid profile alteration, possibly related to the suppression of lipolysis, fatty acid synthesis and fatty acid uptake.